Randomized controlled trial to assess the effect of vitamin K supplementation on the rate of elastin degradation in COPD
- Conditions
- Chronic Obstructive Pulmonary Disease (COPD)
- Registration Number
- NL-OMON20264
- Lead Sponsor
- CIRO+ (Centre of expertise for chronic organ failure)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 40
Inclusion Criteria
Written informed consent
- Diagnosed with COPD based on post-bronchodilator FEV1/FVC <0.70 according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria
Exclusion Criteria
- Pregnant or lactating women, or subjects who intend to become pregnant within the study period
- Subjects using vitamin K as supplements or multivitamin supplements containing vitamin K
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method